Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

15.72
Delayed Data
As of Apr 29
 -0.05 / -0.32%
Today’s Change
14.07
Today|||52-Week Range
18.04
-2.96%
Year-to-Date
No recent news for Grifols SA.

Today’s Trading

Previous close15.77
Today’s open15.75
Day’s range15.59 - 15.80
Volume1,186,838
Average volume (3 months)1,228,558
Market cap$4.0B
Dividend yield2.31%
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.65%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-1.32-2.81%
ICPTIntercept Pharmaceut...-2.94-1.91%
ACADACADIA Pharmaceutica...-0.10-0.31%
UTHRUnited Therapeutics ...+0.36+0.34%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.28
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers

Search for Jobs